Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zyrtec for Copaxone Injection Site Reactions in MS
NCT00240032Phase 4Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Oct 2004
- Primary completion
- Jun 2006
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in injection site reaction (ISR) comparing Copaxone + Zyrtec with Copaxone + Placebo (2 arms). Primary endpoint: Injection Site Reaction at 5 weeks. Started Oct 2004; status: completed.
02
Drugs
cetirizine
03
Conditions
injection site reaction (ISR)
Beyond the preview
Go deeper on NCT00240032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00240032.